Navigating Regulatory CMC Challenges Across Kit-Based & Ready-to-Use Radiopharmaceuticals: An Industry Perspective
Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 08:20
Navigating Regulatory CMC Challenges Across Kit-Based & Ready-to-Use Radiopharmaceuticals: An Industry Perspective was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 3 speakers on record.
Speakers
- Mark Fielding — Speaker Director - Chemistry, Manufacturing, Controls, Regulatory Affairs & Radiopharmaceuticals, AstraZeneca
- Sandra Hennig — Speaker Senior RA CMC Strategist, Bayer
- Anil Lalwani — Speaker Director - Regulatory Chemistry, Manufacturing, Controls & MedTech, Telix Pharmaceuticals